Grexam 250mg Tablet

Introduction to Grexam 250mg Tablet

Grexam 250mg Tablet is a medication primarily used to treat a specific type of lung cancer known as non-small cell lung cancer (NSCLC). It is particularly effective for patients with certain genetic mutations called EGFR mutations. This tablet is usually prescribed to patients who have not undergone chemotherapy before.

Composition of Grexam 250mg Tablet

The active ingredient in Grexam 250mg Tablet is Gefitinib, which is an EGFR tyrosine kinase inhibitor. This means it works by blocking signals that promote cancer cell growth, specifically targeting the mutated EGFR receptors.

Uses of Grexam 250mg Tablet

• Treatment of locally advanced NSCLC
• Treatment of metastatic NSCLC
• Specifically for patients with EGFR mutations

Side effects of Grexam 250mg Tablet

Common side effects:

• Diarrhea
• Skin rash
• Nausea
• Vomiting
• Loss of appetite

Serious side effects:

• Liver toxicity
• Lung inflammation
• Severe diarrhea leading to dehydration

Precautions of Grexam 250mg Tablet

Grexam 250mg Tablet should not be used by individuals who do not have EGFR mutations. It is also contraindicated for pregnant or breastfeeding women, those with severe liver or kidney disease, and individuals with a history of interstitial lung disease. Patients allergic to Gefitinib or any of its ingredients should avoid this medication.

How to Take Grexam 250mg Tablet

• Take one tablet orally once daily.
• Consume the tablet at the same time each day for consistency.
• Swallow the tablet whole with water; do not crush or chew.
• Follow your doctor's instructions regarding dosage and duration.

Conclusion of Grexam 250mg Tablet

Grexam 250mg Tablet is a targeted therapy for treating specific types of lung cancer. It is crucial to follow your healthcare provider's guidance when using this medication to ensure its effectiveness and minimize potential side effects. Always discuss any concerns or symptoms with your doctor to ensure safe and effective treatment.